Worldwide Immuno Oncology Assays Industry to 2026 - Clinical Trials to Cure Different Cancers in Immunotherapy Presents Opportunities
January 05, 2022 06:38 ET
|
Research and Markets
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Immuno Oncology Assays Market Research Report by Indication, Product, Technology, Application, and Region - Global Forecast to 2026 - Cumulative Impact...
Tyrokinse Kinase Inhibitors in the Global Oncology Market 2021: Market Leaders by Indication and Product
November 05, 2021 05:58 ET
|
Research and Markets
Dublin, Nov. 05, 2021 (GLOBE NEWSWIRE) -- The "Oncology Markets for Tyrokinse Kinase Inhibitors" report has been added to ResearchAndMarkets.com's offering. Traditional cancer therapy has focused...
NEW AAD SURVEY: Only a Third of Americans are Concerned About Skin Cancer Despite Nearly 70% Having at Least One Risk Factor
June 15, 2021 14:30 ET
|
American Academy of Dermatology
ROSEMONT, Ill., June 15, 2021 (GLOBE NEWSWIRE) -- With the first day of summer right around the corner, many Americans will increasingly head to the beach or water parks to cool down, but will they...
Sorrento Announces Clinical Research Agreement With Mayo Clinic and FDA Clearance for the First Phase 1b Pilot Study Using Sofusa Lymphatic Drug Delivery Technology to Deliver Ipilimumab in Patients With Melanoma
June 11, 2021 09:00 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO, June 11, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced a research collaboration agreement with Mayo Clinic to conduct human clinical...
Confused About Sunscreen? New American Academy of Dermatology Survey Shows Americans Need a Refresher on Sunscreen Application and SPF
May 25, 2021 14:00 ET
|
American Academy of Dermatology
ROSEMONT, Ill., May 25, 2021 (GLOBE NEWSWIRE) -- With many planning outdoor gatherings this Memorial Day weekend, board-certified dermatologists want to make sure consumers don’t get burned by...
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
May 19, 2021 17:05 ET
|
MacroGenics, Inc.
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have ≥ 50% PSA reduction;...
Global Immuno-Oncology Assays Market (2021 to 2026) - Growing Significance of Companion Diagnostics Presents Opportunities
May 14, 2021 05:23 ET
|
Research and Markets
Dublin, May 14, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Assays Market by Product & Service (Consumables, Instruments, Software), Technology (PCR, NGS, Immunoassay), Cancer Indications...
How to Check Your Nails for Melanoma; American Academy of Dermatology
May 11, 2021 14:00 ET
|
American Academy of Dermatology
ROSEMONT, Ill., May 11, 2021 (GLOBE NEWSWIRE) -- When checking the body for signs of skin cancer, many people may only think to check their skin. However, board-certified dermatologists from the...
New American Academy of Dermatology Survey Finds One-Third of Americans Fail Basic Quiz on Skin Cancer and Sun Exposure
April 27, 2021 14:52 ET
|
American Academy of Dermatology
ROSEMONT, Ill., April 27, 2021 (GLOBE NEWSWIRE) -- In a recent survey of 1,000 U.S. adults, the American Academy of Dermatology found that one-third of Americans lack a basic understanding of skin...
Global Immuno-Oncology Market Report 2021-2026: Merck's Keytruda (Pembrolizumab) Leads the Market
March 29, 2021 06:53 ET
|
Research and Markets
Dublin, March 29, 2021 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Market Analysis, Trends, Opportunities and Unmet Needs - Thematic Research" report has been added to ResearchAndMarkets.com's...